Clinical Trials in Michigan

Browse 243 Michigan Medical Studies Across 1214 Cities
118 Phase 3 Trial · 14607 Michigan Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Michigan

Reviewed by Michael Gill, B. Sc.

Image of Neighborhood Healthcare Institute of Health in Escondido, United States.

Phase-Based Progress Estimates

Tirzepatidefor Overweight

This trial will look at whether tirzepatide can reduce obesity-related health problems and death in adults.

Neighborhood Healthcare Institute of Health (+78 Sites)Call 1-877-CTLILLY (1-877-285-4559 or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of Novo Nordisk Investigational Site in Pembroke Pines, United States.

Phase-Based Progress Estimates

Semaglutide Jfor Diabetes Mellitus, Type 2

This trial is testing a new way to make the diabetes drug semaglutide, to see if it controls blood sugar better than the current version.

Novo Nordisk Investigational Site (+45 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of Dent Neurosciences Research Center Incorporated in Amherst, United States.

Phase-Based Progress Estimates

Eptinezumabfor Migraine

FDA Approved Drug

This trial will investigate the safety of eptinezumab in children and adolescents with chronic or episodic migraines.

FDA Approved Drug

Dent Neurosciences Research Center Incorporated (+3 Sites)Email contact via H. Lundbeck A/SH. Lundbeck A/S

Image of Alliance for Clinical Trials in Oncology in Boston, United States.

Phase-Based Progress Estimates

Quality-of-Life Assessmentfor Stage IV Bladder Cancer AJCC v8

FDA Approved Drug

This trial is testing whether adding radiation therapy to atezolizumab helps people with urothelial cancer live longer compared to atezolizumab alone.

FDA Approved Drug

Alliance for Clinical Trials in Oncology (+54 Sites)Himanshu Nagar

Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IV Pancreatic Cancer AJCC v8

FDA Approved Drug

This trial is testing whether adding pembrolizumab to olaparib, which is the standard of care, is more effective in treating patients with metastatic pancreatic cancer who have BRCA1 or BRCA2 mutations.

FDA Approved Drug

Fairbanks Memorial Hospital (+99 Sites)Vincent Chung

Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Phase-Based Progress Estimates

Quality-of-Life Assessmentfor Metastatic Lung Adenocarcinoma

FDA Approved Drug

This trial is testing pembrolizumab with or without chemotherapy to treat patients with stage IV non-small cell lung cancer that has come back and spread to other places in the body.

FDA Approved Drug

Fairbanks Memorial Hospital (+99 Sites)Aminah Jatoi, MD

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Tucatinibfor Breast

FDA Approved Drug

This trial tests a combination of two drugs to see if they're better than one drug at preventing breast cancer from coming back in patients with high risk, HER2 positive breast cancer.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Ciara C. O'Sullivan, MB, BCh, BAOSeagen Inc.

Image of Penrose-Saint Francis Healthcare in Colorado Springs, United States.

Phase-Based Progress Estimates

Rucaparib Camsylatefor Prostate Cancer

FDA Approved Drug

This trial is testing if a combination of two drugs, rucaparib and enzalutamide, is better than enzalutamide alone for treating men with prostate cancer that has spread and become resistant to testosterone-deprivation therapy.

FDA Approved Drug

Penrose-Saint Francis Healthcare (+99 Sites)Arpit Rao, MD

Image of Research Site in Birmingham, United States.

Phase-Based Progress Estimates

Durvalumab + SoC Chemotherapyfor Carcinoma, Non-Small-Cell Lung

Waitlist Available

FDA Approved Drug

This trial is testing whether a new immunotherapy drug can help prevent cancer from coming back in patients who have had surgery for early-stage lung cancer.

Waitlist Available

FDA Approved Drug

Research Site (+28 Sites)Solange PetersAstraZeneca

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Bilateral Salpingectomyfor Ovarian Carcinoma

This trial compares two surgical procedures for reducing the risk of ovarian cancer in women with BRCA1 mutations.

University of Alabama at Birmingham Cancer Center (+99 Sites)Douglas A Levine

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Endoscopic Ultrasoundfor Pancreatic Cyst

This trial is testing whether more or less frequent monitoring of pancreatic cysts leads to better outcomes for patients.

Anchorage Associates in Radiation Medicine (+99 Sites)David S Weinberg

Image of Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro in Jonesboro, United States.

Phase-Based Progress Estimates

Stereotactic Body Radiation Therapyfor Stage I Lung Cancer AJCC v8

FDA Approved Drug

This trial is testing whether adding atezolizumab to radiation therapy works better than just radiation therapy alone in treating patients with early non-small cell lung cancer.

FDA Approved Drug

Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro (+99 Sites)Megan E Daly

Image of Stanford University in Stanford, United States.

Phase-Based Progress Estimates

Alpha-1 Antitrypsin (AAT)for Graft vs Host Disease

This trial will compare the effectiveness of a combination of AAT and corticosteroids to corticosteroids alone as the first treatment for patients at high risk for developing acute GVHD.

Stanford University (+24 Sites)Study DirectorCSL Behring

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Cytarabinefor Lymphoma

FDA Approved Drug

This trial is testing different combinations of chemotherapy drugs and monoclonal antibodies to treat mantle cell lymphoma.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Nina D Wagner-Johnston

Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Phase-Based Progress Estimates

Cholecalciferolfor Adenocarcinoma

FDA Approved Drug

This trial is testing whether giving vitamin D3 with standard chemo and bevacizumab helps treat colorectal cancer that has spread.

FDA Approved Drug

Fairbanks Memorial Hospital (+99 Sites)Kimmie Ng, MD, MPH

Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Phase-Based Progress Estimates

Bupropion Hydrochloride Controlled-releasefor Breast

FDA Approved Drug

This trial will study how well bupropion works in reducing cancer related fatigue in stage I-III breast cancer survivors.

FDA Approved Drug

Illinois CancerCare-Bloomington (+99 Sites)Heather S Jim

Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Phase-Based Progress Estimates

PI3K Inhibitor Paxalisibfor PI3K Gene Mutation

FDA Approved Drug

This trial looks at whether genetic testing can help guide treatment for brain cancer. Medications that target specific genes may stop the growth of tumor cells.

FDA Approved Drug

Mayo Clinic Hospital in Arizona (+99 Sites)Priscilla Brastianos, MDGenentech, Inc.

Image of Scottsdale HH Cancer Transplant in Scottsdale, United States.

Phase-Based Progress Estimates

Alpha-1 Antitrypsin (AAT)for Graft-vs-Host Disease

Senior-friendly

This trial is testing a new drug to see if it can prevent aGVHD in people undergoing an allogeneic HCT.

Senior-friendly

Scottsdale HH Cancer Transplant (+10 Sites)Study PhysicianCSL Behring

Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Phase-Based Progress Estimates

Esophagectomyfor Squamous cell carcinoma of esophagus

FDA Approved Drug

This trial compares proton beam radiation therapy with intensity modulated photon radiotherapy in treating patients with esophageal cancer.

FDA Approved Drug

Mayo Clinic Hospital in Arizona (+76 Sites)Steven Lin

Image of Community Cancer Institute in Clovis, United States.

Phase-Based Progress Estimates

Inotuzumab Ozogamicinfor Refractory B Acute Lymphoblastic Leukemia

FDA Approved Drug

This trial is testing inotuzumab ozogamicin and blinatumomab to see if they can help treat patients with CD22-positive B-lineage acute lymphoblastic leukemia.

FDA Approved Drug

Community Cancer Institute (+80 Sites)Matthew J Wieduwilt

Image of Katmai Oncology Group in Anchorage, United States.

Phase-Based Progress Estimates

Cabozantinib S-malatefor Argentaffinoma

FDA Approved Drug

This trial compares cabozantinib to placebo in treating neuroendocrine or carcinoid tumors. Cabozantinib is a chemotherapy drug that targets specific tyrosine kinase receptors, which when blocked, may slow tumor growth.

FDA Approved Drug

Katmai Oncology Group (+99 Sites)Jennifer A Chan

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Tazemetostatfor Malignant Neoplasms

Waitlist Available

FDA Approved Drug

This trial looks at how well tazemetostat works in treating patients with ovarian or endometrial cancer that has come back.

Waitlist Available

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Ramez N Eskander

Image of University of Arizona Cancer Center-Orange Grove Campus in Tucson, United States.

Phase-Based Progress Estimates

Cisplatinfor Stage III Lip and Oral Cavity Cancer AJCC v8

FDA Approved Drug

This trial is testing whether radiation therapy is more effective with or without cisplatin in treating patients with squamous cell carcinoma of the head and neck.

FDA Approved Drug

University of Arizona Cancer Center-Orange Grove Campus (+99 Sites)Robert Ferris

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Subprotocol R (BRAF Fusion Or BRAF Non-V600 Mutation)for Lymphoma

FDA Approved Drug

This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Keith T Flaherty

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Quality-of-Life Assessmentfor Recurrent Melanoma

Waitlist Available

FDA Approved Drug

This trial is testing two different treatments for melanoma that cannot be removed by surgery. The first treatment is immunotherapy with monoclonal antibodies, followed by targeted therapy with dabrafenib and trametinib. The second treatment is targeted therapy with dabrafenib and trametinib, followed by immunotherapy with monoclonal antibodies. It is not yet known which treatment is more effective.

Waitlist Available

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Michael B Atkins

25 Michigan Clinical Trials Near Me

Top Cities for Michigan Clinical Trials

Image of Anchorage in Alaska.

Anchorage

270Active Trials

Katmai Oncology GroupTop Active Site

Image of Los Angeles in California.

Los Angeles

254Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site